Health

Chemical companies shore up supplement science

As evidence mounts showing the potential health benefits of probiotics, antioxidants and other nutritional compounds, more and more people are taking supplements. And the chemical industry is getting in on the action. But ...

Oncology & Cancer

Marker may predict response to ipilimumab in advanced melanoma

Among patients with advanced melanoma, presence of higher levels of the protein vascular endothelial growth factor (VEGF) in blood was associated with poor response to treatment with the immunotherapy ipilimumab, according ...

Oncology & Cancer

Investigational PARP inhibitor promising in BRCA-related cancers

An investigational new PARP inhibitor, BMN 673, is showing early responses in patients with heavily pretreated, advanced, BRCA-related cancers of the breast and ovary, according to phase I clinical trial results presented ...

Surgery

Ethics of the commercialization of plastic surgery considered

(HealthDay)—Despite the increasing commercialization of plastic surgery, surgeons have a responsibility to provide individualized treatment to each patient, according to a study published in the September issue of the Aesthetic ...

page 16 from 24